Subarachnoid Hemorrhage Clinical Trial
Official title:
Predictive Value of Mean Flow Velocity by TCD in Early Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Aim of this work is to evaluate the transcranial doppler in prediction of cerebral vasospasm in aneurysmal subarachnoid hemorrhage and also to evaluate their advantages over clinical scales in predicting CV.
Cerebral vasospasm is defined as narrowing of a cerebral blood vessel enough to cause
reduction in distal blood flow. Seventy percent of aSAH patients develop angiographic
vasospasm but only 30% progress to develop evident neurological deficits. Cerebral vasospasm
may be asymptomatic with no clinical symptoms and signs but only abnormal investigations,
such as vascular stenosis by angiography or high blood flow speed by Doppler ultrasound.
Standard tests used to determine the source of bleeding and diagnose cerebral vasospasm (CV)
include neuroimaging studies that administer contrast either intravenously (computed
tomography angiography [CTA]) or intra-arterially (digital subtraction angiography [DSA]).
Cerebral blood flow measurements using computed tomography (CT) perfusion techniques may
detect the degree of cerebral ischemia in a very early stage. Although well-tolerated, these
studies cannot be readily performed on the bedside and expose the patient to additional
radiation, thus significantly restricting their use in daily cerebral hemodynamics
monitoring. Moreover, they involve patient transportation to the CT scanner and utilization
of resources such as nurses, technologists, and ancillary personnel.
Early detection of cerebral vasospasm is an important step in the way of the improvement of
the outcome and the survival of aSAH patients. Transcranial duplex (TCD) is a non-invasive
modality which can assess the cerebral blood vessels diameters and flow velocities that can
be a useful maneuver in early detection of vasospasm after aSAH
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Recruiting |
NCT04189471 -
Recovery After Cerebral Hemorrhage
|
||
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Completed |
NCT05131295 -
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
|
Phase 3 | |
Recruiting |
NCT02962349 -
TRansfusion Strategies in Acute Brain INjured Patients
|
N/A | |
Completed |
NCT02872857 -
Subarachnoid Hemorrhage Recovery And Galantamine
|
Phase 1/Phase 2 | |
Completed |
NCT03164434 -
Influence of Drainage on EVD ICP-signal
|
||
Terminated |
NCT02216513 -
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
|
Phase 0 | |
Not yet recruiting |
NCT00905931 -
Lycopene Following Aneurysmal Subarachnoid Haemorrhage
|
Phase 2 | |
Completed |
NCT02389634 -
Identification of Novel Molecular Markers for Vasospasm
|
||
Completed |
NCT01077206 -
High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage
|
Phase 2/Phase 3 | |
Completed |
NCT00962546 -
Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
|
N/A | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Completed |
NCT00507104 -
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
|
||
Completed |
NCT00071565 -
Familial Intracranial Aneurysm Study II
|
N/A | |
Recruiting |
NCT05113381 -
The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of IVH
|
N/A | |
Completed |
NCT04052646 -
Prehospital Deaths From Spontaneous Subarachnoid Haemorrhages
|
||
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Recruiting |
NCT06033378 -
Blood Pressure Treatment in ICU Patients With Subarachniodal Haemorrhage.
|
N/A | |
Completed |
NCT04308577 -
Diet Induced Ketosis for Brain Injury - A Feasibility Study
|
N/A |